Barclays PLC Royalty Pharma PLC Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Barclays PLC holds 308,887 shares of RPRX stock, worth $7.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

308,887

Previous 308,887 -0.0%

Holding current value

$7.5 Million

Previous $8.74 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$25.63 - $29.27 $1.11 Million - $1.27 Million	43,339 Added 16.32%	308,887 $8.74 Million
Q2 2024 Aug 14, 2024	SELL	$26.26 - $29.9 $507,894 - $578,295	-19,341 Reduced 6.79%	265,548 $7 Million
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $3.22 Million - $3.67 Million	-117,229 Reduced 29.15%	284,889 $8.65 Million
Q4 2023 Feb 15, 2024	SELL	$26.21 - $29.22 $23.9 Million - $26.6 Million	-911,961 Reduced 69.4%	402,118 $11.3 Million
Q3 2023 Nov 07, 2023	BUY	$26.26 - $31.38 $5.53 Million - $6.6 Million	210,414 Added 19.07%	1,314,079 $35.7 Million
Q2 2023 Aug 03, 2023	BUY	$29.6 - $36.56 $19.8 Million - $24.5 Million	670,204 Added 154.62%	1,103,665 $33.9 Million
Q1 2023 May 04, 2023	BUY	$32.77 - $39.4 $1.02 Million - $1.23 Million	31,271 Added 7.78%	433,461 $15.6 Million
Q4 2022 Feb 13, 2023	BUY	$39.17 - $44.04 $7.11 Million - $7.99 Million	181,497 Added 82.24%	402,190 $15.9 Million
Q3 2022 Nov 03, 2022	BUY	$39.88 - $44.65 $395,370 - $442,660	9,914 Added 4.7%	220,693 $8.87 Million
Q2 2022 Aug 12, 2022	BUY	$37.53 - $44.22 $946,469 - $1.12 Million	25,219 Added 13.59%	210,779 $8.86 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $6.95 Million - $7.88 Million	185,560 New	185,560 $7.23 Million

Others Institutions Holding RPRX

# of Institutions

413

Shares Held

283M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account